The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research Report: Functional Annotation of Pseudomonas putida KT2440 mdh (UniProt Q88Q44; locus PP_0654) — probable malate dehydrogenase (EC 1.1.1.37)

0) Executive summary

The UniProt target Q88Q44 corresponds to Pseudomonas putida KT2440 Mdh encoded by mdh / PP_0654, a soluble, NAD-dependent malate dehydrogenase positioned at the malate ⇌ oxaloacetate node of central carbon metabolism. Experimental evidence in KT2440 cell-free extracts demonstrates strong NAD+ preference (~98% NAD+ vs ~2% NADP+ under multiple assay regimes). Recent 2023–2024 multi-omics studies in P. putida metabolic engineering and adaptation track Mdh (PP_0654) abundance/flux and show that removing or down-modulating this node can re-route malate away from oxaloacetate, engage the glyoxylate shunt, and reshape redox/cofactor demands—strategies leveraged for bioproduction and non-native substrate utilization. (nikel2015pseudomonasputidakt2440 pages 21-25, eng2023ensembleanditerative pages 11-13, dvorak2023genomicandmetabolic pages 41-45, dvorak2023genomicandmetabolic pages 20-22)

1) Target verification (mandatory identity checks)

Gene symbol ambiguity resolution. “mdh” can denote different malate dehydrogenase types (cytosolic/mitochondrial in eukaryotes; NAD- vs quinone-dependent oxidoreductases; D-malate dehydrogenases). For this request, multiple independent P. putida KT2440/EM42 studies explicitly refer to malate dehydrogenase Mdh (PP_0654) in central metabolism, matching the UniProt identity and avoiding cross-organism symbol confusion. (dvorak2023genomicandmetabolic pages 41-45, eng2023ensembleanditerative pages 11-13)

Consistency with UniProt annotation. Experimental cofactor specificity for Mdh (PP_0654) in KT2440 supports classification as a canonical NAD-dependent malate dehydrogenase (EC 1.1.1.37), consistent with UniProt’s “probable malate dehydrogenase” assignment. (nikel2015pseudomonasputidakt2440 pages 21-25, nikel2015pseudomonasputidakt2440 media 2fe70d77)

2) Key concepts and current understanding

2.1 Core definition and reaction

Malate dehydrogenase (MDH; EC 1.1.1.37) catalyzes the reversible reaction:

L-malate + NAD+ ⇌ oxaloacetate + NADH + H+. (lorenzo2024catalyticmechanismand pages 1-2)

This enzyme is ubiquitous and central to metabolism; it is commonly positioned to supply oxaloacetate (OAA) to the TCA cycle and to generate NADH that feeds respiratory energy metabolism. (lorenzo2024catalyticmechanismand pages 1-2)

2.2 Mechanism and substrate/cosubstrate specificity (authoritative 2024 synthesis)

A recent mechanistic review (Essays in Biochemistry, 2024) summarizes MDH as following an ordered Bi–Bi (compulsory order) kinetic mechanism (NAD+ binds before malate; products released oxaloacetate then NADH) and highlights active-site loop closure as a key determinant of specificity and catalysis. (lorenzo2024catalyticmechanismand pages 5-7, lorenzo2024catalyticmechanismand pages 7-8)

The review also details conserved catalytic features: a His–Asp catalytic dyad and multiple Arg residues that recognize substrate carboxylates, and reports a large discrimination against non-cognate substrates (e.g., oxaloacetate reduced far faster than pyruvate). (lorenzo2024catalyticmechanismand pages 2-5, lorenzo2024catalyticmechanismand pages 1-2)

Thermodynamically, the equilibrium can strongly favor L-malate/NAD+ under physiological conditions (example values in the review: Keq′ ≈ 2.9×10−5 at 38°C, pH 7; ΔG ≈ +27 kJ/mol), reinforcing that cellular directionality is often set by network context (substrate/product levels and coupling), not just intrinsic enzyme preference. (lorenzo2024catalyticmechanismand pages 1-2)

3) Biochemical function of P. putida Mdh (PP_0654): cofactors and specificity

3.1 Cofactor preference measured in P. putida KT2440

In P. putida KT2440, Mdh was assayed in cell-free extracts from exponential-phase cultures grown on glucose minimal medium. Under saturating conditions, Mdh (PP_0654) showed 98.4 ± 0.7% relative specificity for NAD+ vs 1.6 ± 0.7% for NADP+; under quasi in vivo/non-saturating conditions, 97.5 ± 8.4% NAD+ vs 2.5 ± 1.2% NADP+. (nikel2015pseudomonasputidakt2440 pages 21-25, nikel2015pseudomonasputidakt2440 media 2fe70d77)

These data strongly support that the physiological cofactor for PP_0654 is NAD(H) rather than NADP(H), consistent with canonical TCA-cycle-linked MDH activity. (nikel2015pseudomonasputidakt2440 pages 21-25)

3.2 Kinetic expectations (general MDH literature; not PP_0654-specific)

While direct kinetic constants (Km, kcat) for P. putida PP_0654 were not found in the retrieved pages, the 2024 review compiles representative MDH kinetics across organisms and emphasizes typical patterns: KM(OAA) is commonly lower than KM(L-malate), and KM(NADH) is lower than KM(NAD+), consistent with cellular metabolite availability and the common practice of studying OAA reduction in vitro. (lorenzo2024catalyticmechanismand pages 5-7)

4) Biological role and pathway context in Pseudomonas putida

4.1 Placement in central metabolism (TCA cycle; malate/OAA node)

Recent P. putida studies explicitly annotate Mdh (PP_0654) as part of the TCA cycle and track its abundance as a central node enzyme during adaptation to non-native carbon sources. (dvorak2023genomicandmetabolic pages 41-45)

In a 13C-metabolic flux analysis (MFA) of engineered P. putida grown on D-xylose, malate dehydrogenase is identified among high-flux central dehydrogenase reactions, alongside Zwf/Gnd and pyruvate dehydrogenase, with discussion of flux through the malate/OAA node in relation to the glyoxylate shunt and redox demands. (dvorak2023genomicandmetabolic pages 20-22)

4.2 Coupling to glyoxylate shunt and redox balancing (2023–2024 systems evidence)

During xylose metabolism adaptation in P. putida, MFA and proteomics indicate engagement of the glyoxylate shunt (AceA/GlcB) and suggest interplay between redox balance and shunt activity; different evolved lineages show different patterns of TCA vs glyoxylate usage, with Mdh abundance changing modestly in one lineage and increasing in another where it is argued to support TCA-cycle functioning. (dvorak2023genomicandmetabolic pages 20-22, dvorak2023genomicandmetabolic pages 41-45)

In the 2024 Nature Communications xylose study, the authors explicitly state that upregulation of … malate dehydrogenase Mdh (with other TCA enzymes) “supported functioning of the TCA cycle,” consistent with an adaptive shift toward oxidative metabolism when the glyoxylate shunt is downregulated (e.g., AceA down in the gnd− lineage). (dvorak2024syntheticallyprimedadaptationof pages 11-12)

4.3 Cellular localization

No direct localization experiment for PP_0654 was found in the retrieved sources. However, the KT2440 evidence comes from cell-free extract enzyme assays and central metabolism mapping, supporting the inference that PP_0654 encodes a soluble cytosolic (cytoplasmic) enzyme, typical for bacterial NAD-dependent MDH participating in the TCA cycle. This should be treated as an inference rather than experimentally proven localization within the cited texts. (nikel2015pseudomonasputidakt2440 pages 5-6, lorenzo2024catalyticmechanismand pages 1-2)

5) Recent developments (2023–2024 prioritized): systems biology and metabolic engineering involving PP_0654

5.1 2024: engineered + evolved P. putida for D-xylose utilization (real-world implementation)

A 2024 Nature Communications study used metabolic engineering plus adaptive laboratory evolution to enable and improve P. putida growth on the lignocellulosic sugar D-xylose, with multi-level analysis (including proteomics). In this context, Mdh is part of the tracked central metabolism and is discussed as supporting TCA cycle operation in one evolved lineage. (dvorak2024syntheticallyprimedadaptationof pages 10-11, dvorak2024syntheticallyprimedadaptationof pages 11-12)

Quantitative phenotype data relevant to central rewiring (though not uniquely attributable to mdh alone) show dramatic lag-phase improvements depending on regulatory-genotype context: an engineered strain PD855 exhibited lag phase 4.94 ± 0.39 h, whereas a comparable strain with functional hexR showed lag phase 20.80 ± 0.31 h. This provides a concrete example of how central carbon regulation reshapes the growth phenotype in the metabolic network in which Mdh operates. (dvorak2024syntheticallyprimedadaptationof pages 11-12)

5.2 2023: growth-coupled bioproduction (indigoidine from para-coumarate) exploits the malate/OAA node

A 2023 systems engineering preprint analyzed growth-coupling designs for producing the blue pigment indigoidine from lignin-related carbon (p-coumarate) in P. putida KT2440. In Design 1 strains, proteomics explicitly reported zero protein counts for Mdh/PP_0654, consistent with engineered deletions affecting the malate→oxaloacetate step. (eng2023ensembleanditerative pages 11-13)

Quantitative multi-omics in these strains indicate compensatory rerouting at adjacent nodes: for example, a fumarate→malate isozyme (PP_0897) was 25–30% higher than WT while Mqo3 was reduced to 9–26% of WT; malic enzyme MaeB (malate→pyruvate) was reported at ~2-fold higher protein abundance, consistent with diverting malate away from oxaloacetate production; the glyoxylate shunt enzymes AceA and GlcB were strongly upregulated (reported as multiple-fold changes). (eng2023ensembleanditerative pages 11-13)

Metabolomics further support bottlenecks or rerouting around the fumarate/malate/OAA region (e.g., fumarate 2.7-fold higher in one strain vs WT) with downstream shifts in TCA-linked metabolites and nitrogen assimilation precursors (e.g., AKG and glutamate changes) relevant to indigoidine biosynthesis. (eng2023ensembleanditerative pages 13-16)

6) Statistics and data highlights (recent studies)

6.1 Quantitative cofactor specificity (direct biochemical assay)

The strongest quantitative functional data directly tied to PP_0654 in this evidence set are the NAD-vs-NADP specificity measurements in KT2440 extracts (Table 3 in Nikel et al., 2015). (nikel2015pseudomonasputidakt2440 pages 21-25, nikel2015pseudomonasputidakt2440 media 2fe70d77)

6.2 Quantitative proteomics/metabolomics when Mdh is absent

In the indigoidine engineering context, quantitative proteomics showed Mdh/PP_0654 undetectable (zero counts) and reported numeric relative changes in neighboring nodes (percent-of-WT and ~2-fold values) and glyoxylate shunt upregulation; metabolomics reported a 2.7-fold fumarate increase and multiple fold-changes in central metabolites (e.g., AKG, glutamate, glutamine). (eng2023ensembleanditerative pages 11-13, eng2023ensembleanditerative pages 13-16)

6.3 Expert synthesis: kinetics and thermodynamics

The 2024 MDH review provides representative kinetic constants across MDH isoforms (e.g., OAA KM in the tens of µM and L-malate KM in the hundreds-to-thousands of µM in some cited examples) and highlights that equilibrium/thermodynamics can oppose OAA formation at physiological conditions, reinforcing that MDH flux in vivo is often driven by pathway coupling. (lorenzo2024catalyticmechanismand pages 5-7, lorenzo2024catalyticmechanismand pages 1-2)

7) Interpretation and expert analysis (evidence-based)

1. Functional assignment confidence is high: PP_0654 is repeatedly annotated as Mdh in P. putida KT2440-derived strains, and biochemical assay data show dominant NAD dependence consistent with EC 1.1.1.37 activity. (nikel2015pseudomonasputidakt2440 pages 21-25, dvorak2023genomicandmetabolic pages 41-45)
2. Physiological role is context-dependent: While MDH is formally reversible, modern enzymology emphasizes that cellular directionality is set by metabolite ratios and coupling; the strong thermodynamic bias toward malate under some conditions implies that producing OAA may require pulling flux (e.g., downstream consumption or anaplerotic demands). (lorenzo2024catalyticmechanismand pages 1-2)
3. Engineering leverage point: 2023–2024 studies illustrate that P. putida engineers can exploit the malate/OAA node by lowering Mdh abundance/activity (e.g., eliminating detectable Mdh/PP_0654) to reroute malate carbon (via MaeB) and engage the glyoxylate shunt, consistent with growth-coupled production strategies. (eng2023ensembleanditerative pages 11-13)

8) Evidence summary table

Table: This table summarizes the strongest evidence supporting the functional annotation of Pseudomonas putida KT2440 Mdh (PP_0654; UniProt Q88Q44). It integrates foundational biochemical evidence with 2023-2024 systems studies showing how the enzyme participates in central metabolism and metabolic engineering contexts.

9) Key sources (with URLs and publication dates)

• Nikel PI et al. J Biol Chem. 2015-10. “Pseudomonas putida KT2440 Strain Metabolizes Glucose…” https://doi.org/10.1074/jbc.m115.687749 (nikel2015pseudomonasputidakt2440 pages 21-25, nikel2015pseudomonasputidakt2440 media 2fe70d77)
• Eng TT et al. bioRxiv 2023-03. “Ensemble and Iterative Engineering…” https://doi.org/10.1101/2023.03.16.532821 (eng2023ensembleanditerative pages 11-13, eng2023ensembleanditerative pages 13-16)
• Dvořák P et al. bioRxiv 2023-05. “Genomic and metabolic plasticity…” https://doi.org/10.1101/2023.05.19.541448 (dvorak2023genomicandmetabolic pages 41-45, dvorak2023genomicandmetabolic pages 20-22)
• Dvořák P et al. Nature Communications 2024-03. “Synthetically-primed adaptation…” https://doi.org/10.1038/s41467-024-46812-9 (dvorak2024syntheticallyprimedadaptationof pages 11-12)
• de Lorenzo L et al. Essays in Biochemistry 2024-10. “Catalytic mechanism and kinetics of malate dehydrogenase” https://doi.org/10.1042/ebc20230086 (lorenzo2024catalyticmechanismand pages 1-2, lorenzo2024catalyticmechanismand pages 5-7)

10) Limitations of this evidence set

• Direct enzymatic kinetics (Km/kcat) for P. putida PP_0654 were not located in the retrieved texts; claims about kinetics beyond cofactor preference are therefore supported by general MDH literature rather than PP_0654-specific enzymology. (lorenzo2024catalyticmechanismand pages 5-7, nikel2015pseudomonasputidakt2440 pages 21-25)
• Subcellular localization for PP_0654 was not experimentally demonstrated in the retrieved papers; localization is inferred from soluble assays and canonical bacterial MDH roles. (nikel2015pseudomonasputidakt2440 pages 5-6)
• Essentiality of mdh/PP_0654 in KT2440 was not directly extracted here; thus, no essentiality claim is made.

References

1. (nikel2015pseudomonasputidakt2440 pages 21-25): Pablo I. Nikel, Max Chavarría, Tobias Fuhrer, Uwe Sauer, and Víctor de Lorenzo. Pseudomonas putida kt2440 strain metabolizes glucose through a cycle formed by enzymes of the entner-doudoroff, embden-meyerhof-parnas, and pentose phosphate pathways. Journal of Biological Chemistry, 290:25920-25932, Oct 2015. URL: https://doi.org/10.1074/jbc.m115.687749, doi:10.1074/jbc.m115.687749. This article has 440 citations and is from a domain leading peer-reviewed journal.

2. (eng2023ensembleanditerative pages 11-13): Thomas T Eng, Deepanwita Banerjee, Javier Menasalvas, Yan Chen, Jennifer Gin, Hemant Choudhary, Edward Baidoo, Jian Hua Chen, Axel Ekman, Ramu Kakumanu, Yuzhong Liu Diercks, Alex Codik, Carolyn Larabell, John Gladden, Blake A Simmons, Jay D Keasling, Christopher J Petzold, and Aindrila Mukhopadhyay. Ensemble and iterative engineering for maximized bioconversion to the blue pigment, indigoidine from non-canonical sustainable carbon sources. bioRxiv, Mar 2023. URL: https://doi.org/10.1101/2023.03.16.532821, doi:10.1101/2023.03.16.532821. This article has 1 citations.

3. (dvorak2023genomicandmetabolic pages 41-45): Pavel Dvořák, Barbora Burýšková, Barbora Popelářová, Birgitta Ebert, Tibor Botka, Dalimil Bujdoš, Alberto Sánchez-Pascuala, Hannah Schöttler, Heiko Hayen, Víctor de Lorenzo, Lars M. Blank, and Martin Benešík. Genomic and metabolic plasticity drive alternative scenarios for adapting pseudomonas putida to non-native substrate d-xylose. bioRxiv, May 2023. URL: https://doi.org/10.1101/2023.05.19.541448, doi:10.1101/2023.05.19.541448. This article has 0 citations.

4. (dvorak2023genomicandmetabolic pages 20-22): Pavel Dvořák, Barbora Burýšková, Barbora Popelářová, Birgitta Ebert, Tibor Botka, Dalimil Bujdoš, Alberto Sánchez-Pascuala, Hannah Schöttler, Heiko Hayen, Víctor de Lorenzo, Lars M. Blank, and Martin Benešík. Genomic and metabolic plasticity drive alternative scenarios for adapting pseudomonas putida to non-native substrate d-xylose. bioRxiv, May 2023. URL: https://doi.org/10.1101/2023.05.19.541448, doi:10.1101/2023.05.19.541448. This article has 0 citations.

5. (nikel2015pseudomonasputidakt2440 media 2fe70d77): Pablo I. Nikel, Max Chavarría, Tobias Fuhrer, Uwe Sauer, and Víctor de Lorenzo. Pseudomonas putida kt2440 strain metabolizes glucose through a cycle formed by enzymes of the entner-doudoroff, embden-meyerhof-parnas, and pentose phosphate pathways. Journal of Biological Chemistry, 290:25920-25932, Oct 2015. URL: https://doi.org/10.1074/jbc.m115.687749, doi:10.1074/jbc.m115.687749. This article has 440 citations and is from a domain leading peer-reviewed journal.

6. (lorenzo2024catalyticmechanismand pages 1-2): Laura de Lorenzo, Tyler M.M. Stack, Kristin M. Fox, and Katherine M. Walstrom. Catalytic mechanism and kinetics of malate dehydrogenase. Essays in Biochemistry, 68:73-82, Oct 2024. URL: https://doi.org/10.1042/ebc20230086, doi:10.1042/ebc20230086. This article has 22 citations and is from a peer-reviewed journal.

7. (lorenzo2024catalyticmechanismand pages 5-7): Laura de Lorenzo, Tyler M.M. Stack, Kristin M. Fox, and Katherine M. Walstrom. Catalytic mechanism and kinetics of malate dehydrogenase. Essays in Biochemistry, 68:73-82, Oct 2024. URL: https://doi.org/10.1042/ebc20230086, doi:10.1042/ebc20230086. This article has 22 citations and is from a peer-reviewed journal.

8. (lorenzo2024catalyticmechanismand pages 7-8): Laura de Lorenzo, Tyler M.M. Stack, Kristin M. Fox, and Katherine M. Walstrom. Catalytic mechanism and kinetics of malate dehydrogenase. Essays in Biochemistry, 68:73-82, Oct 2024. URL: https://doi.org/10.1042/ebc20230086, doi:10.1042/ebc20230086. This article has 22 citations and is from a peer-reviewed journal.

9. (lorenzo2024catalyticmechanismand pages 2-5): Laura de Lorenzo, Tyler M.M. Stack, Kristin M. Fox, and Katherine M. Walstrom. Catalytic mechanism and kinetics of malate dehydrogenase. Essays in Biochemistry, 68:73-82, Oct 2024. URL: https://doi.org/10.1042/ebc20230086, doi:10.1042/ebc20230086. This article has 22 citations and is from a peer-reviewed journal.

10. (dvorak2024syntheticallyprimedadaptationof pages 11-12): Pavel Dvořák, Barbora Burýšková, Barbora Popelářová, Birgitta Elisabeth Ebert, Tibor Botka, Dalimil Bujdoš, Alberto Sánchez-Pascuala, Hannah Schöttler, Heiko Hayen, Víctor de Lorenzo, Lars M. Blank, and Martin Benešík. Synthetically-primed adaptation of pseudomonas putida to a non-native substrate d-xylose. Nature Communications, Mar 2024. URL: https://doi.org/10.1038/s41467-024-46812-9, doi:10.1038/s41467-024-46812-9. This article has 37 citations and is from a highest quality peer-reviewed journal.

11. (nikel2015pseudomonasputidakt2440 pages 5-6): Pablo I. Nikel, Max Chavarría, Tobias Fuhrer, Uwe Sauer, and Víctor de Lorenzo. Pseudomonas putida kt2440 strain metabolizes glucose through a cycle formed by enzymes of the entner-doudoroff, embden-meyerhof-parnas, and pentose phosphate pathways. Journal of Biological Chemistry, 290:25920-25932, Oct 2015. URL: https://doi.org/10.1074/jbc.m115.687749, doi:10.1074/jbc.m115.687749. This article has 440 citations and is from a domain leading peer-reviewed journal.

12. (dvorak2024syntheticallyprimedadaptationof pages 10-11): Pavel Dvořák, Barbora Burýšková, Barbora Popelářová, Birgitta Elisabeth Ebert, Tibor Botka, Dalimil Bujdoš, Alberto Sánchez-Pascuala, Hannah Schöttler, Heiko Hayen, Víctor de Lorenzo, Lars M. Blank, and Martin Benešík. Synthetically-primed adaptation of pseudomonas putida to a non-native substrate d-xylose. Nature Communications, Mar 2024. URL: https://doi.org/10.1038/s41467-024-46812-9, doi:10.1038/s41467-024-46812-9. This article has 37 citations and is from a highest quality peer-reviewed journal.

13. (eng2023ensembleanditerative pages 13-16): Thomas T Eng, Deepanwita Banerjee, Javier Menasalvas, Yan Chen, Jennifer Gin, Hemant Choudhary, Edward Baidoo, Jian Hua Chen, Axel Ekman, Ramu Kakumanu, Yuzhong Liu Diercks, Alex Codik, Carolyn Larabell, John Gladden, Blake A Simmons, Jay D Keasling, Christopher J Petzold, and Aindrila Mukhopadhyay. Ensemble and iterative engineering for maximized bioconversion to the blue pigment, indigoidine from non-canonical sustainable carbon sources. bioRxiv, Mar 2023. URL: https://doi.org/10.1101/2023.03.16.532821, doi:10.1101/2023.03.16.532821. This article has 1 citations.

14. (nikel2015pseudomonasputidakt2440 pages 7-8): Pablo I. Nikel, Max Chavarría, Tobias Fuhrer, Uwe Sauer, and Víctor de Lorenzo. Pseudomonas putida kt2440 strain metabolizes glucose through a cycle formed by enzymes of the entner-doudoroff, embden-meyerhof-parnas, and pentose phosphate pathways. Journal of Biological Chemistry, 290:25920-25932, Oct 2015. URL: https://doi.org/10.1074/jbc.m115.687749, doi:10.1074/jbc.m115.687749. This article has 440 citations and is from a domain leading peer-reviewed journal.

15. (dvorak2023genomicandmetabolic pages 22-26): Pavel Dvořák, Barbora Burýšková, Barbora Popelářová, Birgitta Ebert, Tibor Botka, Dalimil Bujdoš, Alberto Sánchez-Pascuala, Hannah Schöttler, Heiko Hayen, Víctor de Lorenzo, Lars M. Blank, and Martin Benešík. Genomic and metabolic plasticity drive alternative scenarios for adapting pseudomonas putida to non-native substrate d-xylose. bioRxiv, May 2023. URL: https://doi.org/10.1101/2023.05.19.541448, doi:10.1101/2023.05.19.541448. This article has 0 citations.

Artifacts

• Edison artifact artifact-00
  

Citations

1. lorenzo2024catalyticmechanismand pages 1-2
2. lorenzo2024catalyticmechanismand pages 5-7
3. dvorak2023genomicandmetabolic pages 41-45
4. dvorak2023genomicandmetabolic pages 20-22
5. dvorak2024syntheticallyprimedadaptationof pages 11-12
6. eng2023ensembleanditerative pages 11-13
7. eng2023ensembleanditerative pages 13-16
8. lorenzo2024catalyticmechanismand pages 7-8
9. lorenzo2024catalyticmechanismand pages 2-5
10. dvorak2024syntheticallyprimedadaptationof pages 10-11
11. dvorak2023genomicandmetabolic pages 22-26
12. https://doi.org/10.1074/jbc.m115.687749;
13. https://doi.org/10.1101/2023.05.19.541448;
14. https://doi.org/10.1038/s41467-024-46812-9
15. https://doi.org/10.1042/EBC20230086
16. https://doi.org/10.1074/jbc.m115.687749
17. https://doi.org/10.1038/s41467-024-46812-9;
18. https://doi.org/10.1101/2023.03.16.532821
19. https://doi.org/10.1101/2023.05.19.541448
20. https://doi.org/10.1042/ebc20230086
21. https://doi.org/10.1074/jbc.m115.687749,
22. https://doi.org/10.1101/2023.03.16.532821,
23. https://doi.org/10.1101/2023.05.19.541448,
24. https://doi.org/10.1042/ebc20230086,
25. https://doi.org/10.1038/s41467-024-46812-9,

Functional Annotation Report: mdh (Q88Q44 / PP_0654) — NAD-dependent Malate Dehydrogenase of Pseudomonas putida KT2440

Summary

The gene mdh (UniProt Q88Q44; ordered locus PP_0654) of Pseudomonas putida KT2440 encodes a cytoplasmic, NAD⁺-dependent malate dehydrogenase (MDH; EC 1.1.1.37). Its primary function is to catalyze the reversible, NAD⁺-dependent oxidation of L-(S)-malate to oxaloacetate, the final oxidative step of the tricarboxylic acid (TCA) cycle, coupled to the reduction of NAD⁺ to NADH. This is a core, house-keeping reaction of central carbon metabolism, and the enzyme is a member of the ubiquitous LDH/MDH superfamily, specifically the type-3 (bacterial/archaeal) MDH subfamily with the classic bilobal fold — an N-terminal Rossmann NAD-binding domain and a C-terminal α+β substrate-binding/dimerization domain.

Multiple lines of evidence converge on this assignment. UniProt annotates Q88Q44 as a probable malate dehydrogenase with the TCA-cycle and NAD keywords, and the InterPro domain architecture (IPR001557, IPR001236, IPR022383, IPR011275, IPR015955) places it squarely in the malate/lactate dehydrogenase fold with the type-3 MDH signature. A global sequence alignment against the biochemically characterized E. coli MDH (P61889, the ECO:0000250 annotation anchor) shows 34.8 % identity with complete conservation of the catalytic and substrate-binding machinery: the proton-acceptor histidine and a substrate-carboxylate-binding arginine triad, including the specificity-determining active-site loop arginine that discriminates the C4 dicarboxylate (malate/oxaloacetate) from the C3 substrate (lactate/pyruvate) of the homologous lactate dehydrogenases.

Functionally, the enzyme operates as a soluble homodimer in the cytoplasm (bacteria lack organelles; there is no signal peptide or transmembrane segment). It is distinct from the unrelated membrane-associated, FAD-dependent malate:quinone oxidoreductase (MQO, EC 1.1.99.16), which performs the same net chemistry but feeds electrons directly into the quinone pool. Because the reaction is freely reversible, mdh supports both directions of flux: in the oxidative TCA direction it regenerates oxaloacetate for citrate synthase and supplies cytosolic NADH to the respiratory chain, while in the reductive direction it supports oxaloacetate reduction for redox balancing and anaplerotic/gluconeogenic malate formation. In the closely related Gammaproteobacterium E. coli, deletion of the orthologous NAD-MDH severely impairs growth on several substrates — establishing that this enzyme class, rather than MQO, is the physiologically dominant malate-oxidizing activity in this lineage, which includes P. putida.

Gene Identity Verification

The target identity was verified against every available identifier, and all lines of evidence are mutually consistent — there is no ambiguity in this case:

• Gene symbol vs. protein description: the symbol mdh is the standard symbol for malate dehydrogenase and matches the UniProt description "Probable malate dehydrogenase, EC 1.1.1.37."
• Organism: UniProt Q88Q44 organism is Pseudomonas putida KT2440 (PSEPK), exactly the target strain.
• Family/domains: the InterPro domains (IPR001557, IPR001236, IPR022383, IPR011275, IPR015955) and the LDH/MDH superfamily assignment align with the malate dehydrogenase literature retrieved.

No conflicting literature for a different gene with the same symbol in a different organism affected the analysis. The report proceeds with high confidence in the identity.

Key Findings

F001 — mdh encodes NAD-dependent malate dehydrogenase (EC 1.1.1.37) catalyzing reversible L-malate ⇌ oxaloacetate

The core identity of the gene product is firmly established. UniProt entry Q88Q44 assigns gene mdh, ordered locus name PP_0654, the description "Probable malate dehydrogenase," EC number 1.1.1.37, and the organism Pseudomonas putida KT2440 — matching the target identity exactly. The canonical reaction catalyzed by MDH is the reversible NAD⁺-dependent interconversion of L-malate and oxaloacetate. This is corroborated by a comprehensive 2024 review of MDH catalytic mechanism and kinetics (PMID: 38721782), which states plainly that the enzyme "catalyzes the reversible NAD⁺-dependent reduction of L-malate to oxaloacetate."

The family assignment is fully consistent with this catalytic role. Q88Q44 carries the InterPro signatures of the LDH/MDH superfamily — L-lactate/malate_DH (IPR001557), the N-terminal Lactate/malate_DH_N domain (IPR001236), the C-terminal Lactate/malate_DH_C domain (IPR022383), and, critically, the Malate_DH_type3 signature (IPR011275). Together, the database annotation and the canonical enzymology define the reaction:

(S)-malate + NAD⁺  ⇌  oxaloacetate + NADH + H⁺        (EC 1.1.1.37)

F002 — Substrate specificity is set by an active-site loop arginine (Arg102), distinguishing MDH from lactate dehydrogenase

MDHs and lactate dehydrogenases (LDHs) are homologous core-metabolic enzymes that share a common fold and catalytic mechanism yet possess strict specificity for their respective substrates (PMID: 24966208; PMID: 31301348). The molecular basis of this discrimination is remarkably economical: a single residue in the active-site loop governs substrate specificity — an arginine (Arg102) in MDHs versus a glutamine (Gln102) in LDHs (Boucher et al., PMID: 24966208). The arginine provides a positively charged contact for the second (C4) carboxylate of the dicarboxylic substrate malate/oxaloacetate, whereas the neutral glutamine in LDHs accommodates the smaller, mono-carboxylate lactate/pyruvate.

This principle is directly relevant to Q88Q44 because it provides a structural rule for inferring substrate selectivity from sequence. The 2024 review further notes that mutations in and around the substrate-enclosing active-site loop can alter substrate/cosubstrate specificity (PMID: 38721782), underscoring that this loop is the decisive specificity element.

F003 — Catalytic and substrate-binding residues are fully conserved in Q88Q44 (34.8 % identity to characterized E. coli MDH)

A global Needleman–Wunsch alignment of Q88Q44 (278 aa) against its ECO:0000250 annotation anchor, the biochemically characterized E. coli MDH P61889 (312 aa), gives 34.8 % identity over 270 aligned positions. More important than the overall identity is that the entire MDH catalytic constellation is conserved at the aligned positions:

UniProt lists His144 as the active-site proton acceptor and these positions as binding sites. The substrate-binding Arg120 (corresponding to E. coli Arg153) is the second-carboxylate/specificity arginine that discriminates the C4 dicarboxylate malate/oxaloacetate from the C3 lactate/pyruvate. Because MDH and LDH share fold and mechanism but differ in specificity (PMID: 24966208), the conservation of the full arginine constellation is strong sequence-based evidence that Q88Q44 is a bona fide malate — not lactate — dehydrogenase, catalytically equivalent to the well-studied enteric enzyme.

F004 — mdh functions in the cytoplasm as the TCA-cycle malate→oxaloacetate step

UniProt Q88Q44 carries the keywords "Tricarboxylic acid cycle" and "NAD," with the FUNCTION line "Catalyzes the reversible oxidation of malate to oxaloacetate" and the catalytic activity (S)-malate + NAD⁺ = oxaloacetate + NADH + H⁺ (EC 1.1.1.37). As a soluble bacterial NAD-dependent MDH with no signal peptide or transmembrane segment, it necessarily operates in the cytoplasm — bacteria have no membrane-bound organelles, and MDHs are canonically soluble cytoplasmic enzymes (PMID: 38721782: "MDH ... plays vital roles in the cytoplasm and various organelles").

In the specific physiological context of P. putida KT2440, the TCA cycle forms part of a tightly regulated, transcriptionally invariant central carbon metabolism, while glucose is catabolized primarily through the Entner–Doudoroff pathway rather than the classical Embden–Meyerhof–Parnas (EMP) glycolysis (Sudarsan et al., PMID: 24951791: "the canonical Entner-Doudoroff and EMP pathways sensu stricto are not a part of central carbon metabolism in P. putida"). Within this network, mdh performs the last oxidative step of the TCA cycle, regenerating oxaloacetate to condense with acetyl-CoA at citrate synthase.

F005 — Q88Q44 is a type-3 MDH with a two-domain architecture: N-terminal Rossmann NAD-binding fold + C-terminal α+β substrate domain

InterPro classifies the diagnostic signature IPR011275 "Malate dehydrogenase, type 3" as encompassing "bacterial and archaeal malate dehydrogenases, which convert malate into oxaloacetate in the citric acid cycle," a group defined by "the critical residues which discriminate malate dehydrogenase from lactate dehydrogenase." The enzyme adopts the canonical LDH/MDH bilobal fold: the N-terminal domain (IPR001236) is a Rossmann-type dinucleotide (NAD)-binding fold, and the C-terminal domain (IPR022383; with IPR015955 describing the C-terminal α+β region) provides substrate binding and dimerization. The sequence begins MDVQGELAQGKALDVWQ…, consistent with an N-terminal dinucleotide-binding lobe. This architecture explains the mechanism: NAD⁺ binds in the Rossmann lobe, malate/oxaloacetate binds in the C-terminal lobe, and catalysis proceeds via hydride transfer to/from the nicotinamide C4 with the conserved histidine acting as the general acid/base.

F006 — Q88Q44 is the cytoplasmic NAD-MDH, distinct from membrane MQO, and physiologically dominant for malate oxidation in Gammaproteobacteria

Bacteria can oxidize L-malate to oxaloacetate by two unrelated enzymes: the cytoplasmic NAD-dependent MDH (EC 1.1.1.37) and the membrane-associated, FAD-dependent malate:quinone oxidoreductase (MQO; EC 1.1.99.16; gene mqo/yojH), which donates electrons directly to quinones of the electron-transport chain (van der Rest et al., PMID: 11092847: "Oxidation of malate to oxaloacetate in Escherichia coli can be catalyzed by two enzymes: the well-known NAD-dependent malate dehydrogenase (MDH; EC 1.1.1.37) and the membrane-associated malate:quinone-oxidoreductase (MQO; EC 1.1.99.16)"; Kather et al., PMID: 10809701). Q88Q44 is annotated EC 1.1.1.37 (NAD-dependent) and lacks any FAD-binding or membrane features, unambiguously identifying it as the cytoplasmic NAD-MDH, not MQO.

Crucially, gene-deletion experiments in E. coli establish which enzyme dominates physiologically: "a defined deletion of the mdh gene led to severely decreased rates of growth on several substrates. Deletion of the mqo gene did not produce a distinguishable effect on the growth rate" (PMID: 11092847). This demonstrates that in this Gammaproteobacterial lineage — which includes P. putida — the NAD-MDH is the physiologically dominant malate-oxidizing enzyme and is important for growth. Notably, the picture differs in the Actinobacterium Corynebacterium glutamicum, where MQO is dominant and an mdh deletion alone shows no phenotype (PMID: 11092846) — highlighting that the E. coli result is the more appropriate model for P. putida.

F007 — Q88Q44 is a homodimeric NAD(H)-dependent MDH contributing cytosolic NADH to respiration and supporting reversible anaplerotic/gluconeogenic flux

Within the LDH/MalDH superfamily, the canonical LDHs and the LDH-like group of malate dehydrogenases are "primarily tetrameric enzymes that diverged from a common ancestor" (PMID: 31301348), whereas the non-LDH-like (type-3 / "mitochondrial-like") MDH group — to which Q88Q44 belongs, and which includes E. coli MDH and mitochondrial MDH — forms homodimers. Characterized NAD-MDHs of this class are indeed homodimers in solution (e.g., plastidial NAD-MDH shown by gel filtration and glutaraldehyde cross-linking, PMID: 26095832). Q88Q44 is therefore predicted to be a homodimer.

Directionally, because the reaction (S)-malate + NAD⁺ ⇌ oxaloacetate + NADH + H⁺ is freely reversible (PMID: 38721782: "It catalyzes the reversible NAD⁺-dependent reduction of L-malate to oxaloacetate"), the enzyme performs two physiological roles. In the oxidative TCA direction it generates cytosolic NADH, which is reoxidized by the respiratory NADH dehydrogenases feeding the electron-transport chain. In the reductive direction it supports oxaloacetate reduction for redox balancing and gluconeogenesis. KM values of MDH isozymes are generally tuned to physiological substrate concentrations (PMID: 38721782), consistent with an enzyme poised to operate near equilibrium in either direction depending on cellular demand.

Mechanistic Model / Interpretation

The findings assemble into a coherent, well-supported model of mdh (PP_0654) as a canonical cytoplasmic NAD-dependent malate dehydrogenase performing the terminal oxidative step of the TCA cycle in P. putida KT2440.

Catalytic cycle and role in the TCA cycle:

 acetyl-CoA
     │  (citrate synthase)
     ▼
   oxaloacetate ──────────────► citrate
▲                          │
│                          ▼
  ┌─────┴──────┐              (TCA cycle)
  │  mdh /     │                    │
  │  PP_0654   │  NAD⁺→NADH         ▼
  │ (NAD-MDH,  │◄───────────── L-malate
  │  cytoplasm)│
  └────────────┘
│
   NADH → respiratory chain (NADH dehydrogenases) → proton-motive force → ATP

The enzyme takes L-malate, abstracts a hydride from its C2 carbon to NAD⁺ (yielding NADH), with the conserved active-site His144 acting as the general base that deprotonates the substrate hydroxyl; the resulting oxaloacetate is stabilized by the arginine triad (Arg51/Arg57/Arg120). Arg120 in particular anchors the C4 carboxylate that defines dicarboxylate (malate/OAA) specificity, the feature that distinguishes MDH from its LDH cousins. The oxaloacetate produced is the obligatory co-substrate for citrate synthase, closing the TCA cycle, while the NADH produced is oxidized by the respiratory chain to drive ATP synthesis.

Two malate-oxidizing enzymes, one dominant:

The comparison makes the physiological logic explicit: P. putida, like E. coli, relies on the reversible NAD-MDH as its principal malate/oxaloacetate interconverting enzyme. Reversibility is the key functional advantage — it lets the same enzyme serve TCA-cycle oxidation when carbon flows toward respiration, and oxaloacetate reduction (malate formation) when the cell runs gluconeogenesis or needs to balance the NADH/NAD⁺ pool. This dual capacity is especially relevant in P. putida, a metabolically versatile soil organism whose central carbon metabolism must accommodate diverse carbon sources (sugars via Entner–Doudoroff, plus organic and aromatic acids that feed the TCA cycle at oxaloacetate and other nodes).

Structural summary: Q88Q44 is a two-domain, Rossmann-fold NAD-binding + α/β substrate-binding homodimer of the type-3 MDH subfamily, cytoplasmic, ~278 residues, with a fully conserved catalytic and specificity apparatus. Every layer of evidence — database annotation, domain architecture, residue-level sequence conservation against a characterized ortholog, family-level oligomeric rules, and comparative gene-deletion physiology — is mutually consistent.

Evidence Base

Supporting/contextual literature reviewed includes structural studies of human mitochondrial MDH2 (phosphate binding and active conformation, PMID: 36139014), enzyme promiscuity/HGT in metabolic evolution (PMID: 31858709), and P. putida systems-level metabolic studies (PMID: 30936206, PMID: 41176845). None of these contradict the assignment; they reinforce the enzyme's placement in central carbon metabolism.

Limitations and Knowledge Gaps

1. No direct biochemical characterization of Q88Q44 itself. The functional assignment rests on (a) UniProt/InterPro annotation, (b) sequence conservation against the characterized E. coli ortholog (34.8 % identity), and (c) family-level generalizations. There is, to our knowledge, no published purification, kinetic measurement (kcat, KM for malate/OAA/NAD⁺/NADH), or crystal structure of the specific P. putida KT2440 PP_0654 protein. The enzyme is annotated "Probable."

2. Oligomeric state is inferred, not measured. The homodimer prediction is based on subfamily membership (type-3, non-LDH-like), not on gel filtration or crystallography of Q88Q44.

3. Directional/kinetic preference in vivo is unquantified. While the reaction is thermodynamically reversible, the actual net flux direction in P. putida under given growth conditions (respiratory vs gluconeogenic) has not been directly measured for this enzyme.

4. Gene-essentiality/phenotype data are extrapolated from E. coli. The severe growth defect of Δmdh was demonstrated in E. coli, not in P. putida. Although both are Gammaproteobacteria, P. putida has distinctive central metabolism (Entner–Doudoroff dominance), so a direct P. putida Δmdh phenotype would strengthen the physiological claim.

5. Possible redundancy with MQO in P. putida is uncharacterized. P. putida likely also encodes an MQO; the relative contributions of PP_0654 (NAD-MDH) and any MQO to malate oxidation in this organism have not been experimentally partitioned.

Proposed Follow-up Experiments / Actions

1. Recombinant expression and enzymology. Clone PP_0654, express in E. coli, purify, and measure steady-state kinetics in both directions (malate oxidation and OAA reduction), determining kcat and KM for malate, oxaloacetate, NAD⁺, and NADH, and confirming strict NAD (not NADP) preference. This would convert the "Probable" annotation to experimentally validated (evidence code EXP).

2. Oligomeric state and structure. Determine the oligomeric state by size-exclusion chromatography and/or SEC-MALS, and pursue a crystal or cryo-EM structure (ideally with NAD and a substrate analogue) to confirm the type-3 dimeric fold and the roles of His144 and the Arg51/Arg57/Arg120 triad.

3. Targeted gene deletion in P. putida KT2440. Construct a clean ΔPP_0654 mutant and assay growth on TCA-feeding substrates (e.g., succinate, malate, aromatic-derived intermediates that funnel to oxaloacetate) versus glucose. Compare with a Δmqo single mutant and the Δmdh Δmqo double mutant to partition malate-oxidizing activity and test whether the E. coli-like dominance of NAD-MDH holds in P. putida.

4. Site-directed mutagenesis of the specificity arginine (Arg120). Mutate Arg120→Gln and test whether substrate preference shifts toward pyruvate/lactate, experimentally validating the MDH-vs-LDH specificity determinant in this specific enzyme.

5. ¹³C metabolic flux analysis. Use isotope tracing under respiratory and gluconeogenic conditions to measure the net directional flux through the malate/oxaloacetate node and quantify the enzyme's contribution to cytosolic NADH generation versus anaplerotic malate formation.

Conclusion

All available evidence — UniProt/InterPro annotation, the type-3 MDH domain signature, 34.8 % identity with complete conservation of the catalytic His and specificity arginine triad relative to characterized E. coli MDH, family-level oligomeric rules, and comparative gene-deletion physiology in Gammaproteobacteria — consistently identifies Q88Q44 / PP_0654 (mdh) as a cytoplasmic, homodimeric, NAD⁺-dependent malate dehydrogenase (EC 1.1.1.37) performing the terminal oxidative step of the TCA cycle in P. putida KT2440. It catalyzes the reversible oxidation of L-(S)-malate to oxaloacetate, regenerating oxaloacetate for citrate synthase and supplying NADH to the respiratory chain, while its reversibility supports anaplerotic/gluconeogenic flux. It is distinct from, and physiologically dominant over, the membrane FAD-dependent MQO in this lineage. The gene symbol, organism, and protein family are all internally consistent — this is the correct target, and no ambiguity was encountered.

Artifacts

• OpenScientist final report
• OpenScientist final report

Citations

1. PMID:38721782
2. PMID:24966208
3. PMID:31301348
4. PMID:24951791
5. PMID:11092847
6. PMID:10809701
7. PMID:11092846
8. PMID:26095832
9. PMID:36139014
10. PMID:31858709
11. PMID:30936206
12. PMID:41176845